Article Details
Retrieved on: 2025-02-13 23:18:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Roche's Evrysdi was just approved in a new tablet formulation. Spinraza sales remain below Roche's Evrsydi, but Biogen is eyeing growth (Shutterstock).
Article found on: insights.citeline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here